NIHR Manchester Biomedical Research Centre

Greater Manchester has a deep heritage in science, innovation and entrepreneurship.

The NIHR Manchester Biomedical Research Centre (BRC) connects world-leading researchers based at The University of Manchester and three NHS Trusts in Greater Manchester, with a joint vision to drive forward the transformation of scientific breakthroughs into life-saving treatments and care for patients.

Manchester BRC researchers receive academic promotions

Posted: Wednesday, September 11, 2019

Researchers at the NIHR Manchester Biomedical Research Centre (BRC) have recently been awarded academic promotions by The University of Manchester.

Former Government Minister, Baroness Estelle Morris, to attend conference on rare disease research

Posted: Tuesday, September 10, 2019

Former MP and Education Minister, Baroness Estelle Morris, is lending her support to ‘one of the most important’ conferences about research into a rare disease. The 16th International Congress on Antiphospholipid Antibodies (ICAPA), will be chaired by our Director, Professor Ian Bruce.

View More News

Introducing the NIHR Manchester BRC

We will drive forward pioneering research into new tests and treatments in musculoskeletal disease, hearing health, respiratory disease, dermatology and three cancer themes (prevention, radiotherapy and precision medicine), utilising our expertise in biomarkers, informatics and the rapid translation of research findings.

You can help shape our research

There are plently of opportunities for people to help shape our research plans. Research is vital to help us understand more about a particular disease or condition and how to treat them.

Recent Blog Articles

Can we win the fight against sepsis and antibiotic resistance?

Posted: Friday, September 13, 2019 Author: Dr Timothy Felton

On World Sepsis Day Dr Timothy Felton discusses how Manchester BRC is rising to the challenge of tackling sepsis in the face of the increasing challenge posed by antibiotic resistance.

Posted: Tuesday, September 3, 2019 Author: Professor Cynthia Morton

Professor Cynthia Morton, Programme Lead for Genetic and Genomic Solutions, discusses her project to expand newborn hearing screening to include genetic screening for variants in genes known to cause deafness.

Opportunities for partnership working

We’re looking to build collaborations with industry, public and charity partners to deliver on our ambitious plans.

The development of new clinical tests and treatments requires significant investment, specialist facilities and a diverse skillset, only made possible through a collaborative approach.